AGP Executive Report
Last update: 3 hours agoEmergency Care: Soroka Medical Center has opened an expanded emergency department, strengthening capacity after the October 7 attacks. Caregiver Support: A $3 million Genesis Prize program will fund 26 Israeli organizations providing training, supervision and resources for mental-health professionals, social workers, educators and emergency responders. Cancer Research: Sheba Medical Center approved a Phase 2b/3 trial of Racura Oncology’s investigational AML drug RC220; patient dosing is planned for early 2027. Regenerative Medicine: Israeli-linked biotech NurExone reported nerve-fiber regrowth in a laboratory study of injured human motor neurons treated with ExoPTEN, an early-stage finding that has not yet been tested as a treatment in patients.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.